Overview

Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain

Status:
Terminated

Trial end date:
2004-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and efficacy of pain control by fentanyl, administered via adhesive skin patches, at doses of 25 to 100 micrograms per hour in 80 out-patients with intense chronic cancer pain. Higher doses are allowed by permission of the investigator and rescue oral morphine medication is allowed.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen Cilag S.A.S.

Treatments:

Fentanyl